Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5).

Antimicrobial Agents and Chemotherapy
Beda JoosHuldrych F Günthard

Abstract

While certain antibodies directed against the human immunodeficiency virus (HIV) envelope have the potential to suppress virus replication in vitro, the impact of neutralizing antibodies in vivo remains unclear. In a recent proof-of-concept study, the broadly neutralizing monoclonal antibodies 2G12, 4E10, and 2F5 exhibited inhibitory activities in vivo, as exemplified by a delay of the viral rebound following the interruption of antiretroviral therapy. Unexpectedly, the antiviral effect seen was most prominently due to 2G12 activity. To further investigate whether differential HIV-inhibitory activity was due to different pharmacokinetic properties of the antibodies, we performed a formal pharmacokinetic analysis with 14 patients. Repeated infusions at high dose levels were well tolerated by the patients and did not elicit an endogenous immune response against the monoclonal antibodies. The pharmacokinetic parameters of all three antibodies correlated with each other. Mean estimates were 0.047, 0.035, and 0.044 liter/kg for the central volume of distribution of 2G12, 4E10, and 2F5, respectively, and 0.0018, 0.0058, and 0.0077 liter/kg . day for the systemic clearance of 2G12, 4E10, and 2F5, respectively. Monoclonal antibody 2G12...Continue Reading

References

Dec 1, 1994·AIDS Research and Human Retroviruses·M PurtscherA Jungbauer
Jun 1, 1996·Clinical Pharmacology and Therapeutics·E J WolfeJ G Gambertoglio
Jul 1, 1997·The Journal of Allergy and Clinical Immunology·T B CasaleD C Adelman
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·T W ChunA S Fauci
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S GordonD Adelman
Jan 25, 2002·AIDS·Christine ArmbrusterHermann W D Katinger
Apr 24, 2003·Clinical Pharmacology and Therapeutics·Howard LeeCarl C Peck
Jan 15, 2004·The Journal of Infectious Diseases·Daniel R KuritzkesWilliam R Shanahan
Sep 25, 2004·Journal of Pharmaceutical Sciences·Evelyn D LoboJoseph P Balthasar
Oct 1, 2004·The Journal of Antimicrobial Chemotherapy·Christine ArmbrusterHermann W D Katinger
Nov 30, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Bruce J DezubeRobert A Mastico
Jan 22, 2005·Annual Review of Medicine·Norman L Letvin

❮ Previous
Next ❯

Citations

Nov 2, 2012·Clinical and Vaccine Immunology : CVI·Vincent J VendittoFrancis C Szoka
Nov 23, 2007·Journal of Virology·Alexandra TrkolaHuldrych F Günthard
Jan 8, 2013·BMC Medicine·Michela FlegoStefano Vella
Dec 29, 2010·PLoS Pathogens·Xin M LuoDavid Baltimore
Apr 3, 2012·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Rui GongDimiter S Dimitrov
Mar 12, 2010·Uirusu·Takushi Nomura, Tetsuro Matano
Apr 20, 2014·BioMed Research International·Matilde MerlinLinda Avesani
Jun 15, 2007·Journal of Virology·Amapola ManriqueAlexandra Trkola
Feb 5, 2016·Current HIV/AIDS Reports·Kathryn E Stephenson, Dan H Barouch
Mar 13, 2013·Protein & Cell·Yuanxi KangZhiwei Chen
Feb 28, 2009·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Ting-Ting FengNan-Ping Wu
Sep 17, 2010·ChemMedChem·Maria HertjeUrsula Dietrich
Mar 21, 2016·Current Opinion in Immunology·Davide Corti, Jeffrey D Kearns
Aug 18, 2009·Antiviral Research·John C Tilton, Robert W Doms
Dec 23, 2016·The Journal of Experimental Medicine·Amelia EscolanoMichel C Nussenzweig
Dec 13, 2017·Frontiers in Microbiology·Simona A Iacob, Diana G Iacob
Jan 20, 2018·Expert Review of Anti-infective Therapy·Said A Hassounah, Thibault Mesplède
Feb 2, 2016·Advanced Drug Delivery Reviews·Casey K Hua, Margaret E Ackerman
Jun 13, 2019·Journal of the American Chemical Society·Lauren C SmithKim D Janda
Sep 18, 2021·Frontiers in Immunology·E Fabian Cardozo-Ojeda, Alan S Perelson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.